Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary

Nicolas Clementy1, Bertrand Pierre, Bénédicte Lallemand

  • 1Cardiology B Department, Service de Cardiologie B, Trousseau Hospital, François Rabelais University, 37044 Tours, France. nclementy@yahoo.fr

Insights

High-rate cut-off programming for implantable cardioverter defibrillators (ICDs) in patients with reduced ejection fraction is safe long-term. This approach significantly lowers ICD shocks, which can be harmful in this population.

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Background:

  • Implantable cardioverter defibrillators (ICDs) reduce mortality in patients with left ventricular systolic dysfunction.
  • High-rate cut-off programming may decrease ICD therapies but its long-term impact is unclear, leading to underutilization.

Purpose of the Study:

  • To evaluate the safety and efficacy of high-rate cut-off (220 b.p.m.) shock-only ICD programming in primary prevention patients.
  • To assess the long-term consequences of this programming strategy on morbidity and mortality.

Main Methods:

  • Prospective study of 365 patients with cardiomyopathy and left ventricular dysfunction receiving an ICD for primary prevention.
  • Devices programmed with a shock-only zone >220 b.p.m. and a monitoring zone of 170-220 b.p.m.
  • Median follow-up of 40 months.

Main Results:

  • 41 patients (11.2%) received appropriate shocks; 24 (6.6%) received inappropriate shocks.
  • 84% of patients experienced no ICD shocks during follow-up.
  • Ventricular tachycardia episodes were recorded in the monitoring zone in 11.8% of patients, with only 1.9% symptomatic.

Conclusions:

  • High-rate cut-off (220 b.p.m.) shock-only ICD programming is safe in the long term for primary prevention patients with reduced ejection fraction.
  • This strategy results in a very low rate of ICD discharges, avoiding potentially deleterious shocks in this vulnerable population.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...